References
- Victoria JG, Wang C, Jones MS, Jaing C, McLoughlin K, Gardner S, Delwart EL. Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus. J Virol 2010; 84:6033-40; PMID:20375174; https://doi.org/http://dx.doi.org/10.1128/JVI.02690-09
- Cortese MM, Parashar UD. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009; 58:1-25; PMID:19194371
- US Food and Drug Administration. Information for parents and caregivers. 2010. Available at: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm205547.htm. Accessed 05 April 2016.
- McClenahan SD, Krause PR, Uhlenhaut C. Molecular and infectivity studies of porcine circovirus in vaccines. Vaccine 2011; 29:4745-53; PMID:21569811; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2011.04.087
- Baylis SA, Finsterbusch T, Bannert N, Blumel J, Mankertz A. Analysis of porcine circovirus type 1 detected in Rotarix vaccine. Vaccine 2011; 29:690-7; PMID:21093497; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2010.11.028
- Howe B. Vaccines and related biological products advisory committee meeting: ROTARIX (Rotavirus Vaccine, Live Oral): GSK's PCV1 Investigation (PPTX - 2.4MB). 2010. Available at: http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/ucm211828.htm. Accessed 05 April 2016.
- Esona MD, Mijatovic-Rustempasic S, Yen C, Parashar UD, Gentsch JR, Bowen MD, LaRussa P. Detection of PCV-2 DNA in stool samples from infants vaccinated with RotaTeq®. Hum Vaccin Immunother 2014; 10:25-32; PMID:24104203; https://doi.org/http://dx.doi.org/10.4161/hv.26731
- Payne DC, Currier RL, Staat MA, Sahni LC, Selvarangan R, Halasa NB, Englund JA, Weinberg GA, Boom JA, Szilagyi PG, et al. Epidemiologic association between FUT2 secretor status and severe rotavirus gastroenteritis in children in the United States. JAMA Pediatr 2015; 169:1040-5; PMID:26389824; https://doi.org/http://dx.doi.org/10.1001/jamapediatrics.2015.2002
- Currier RL, Payne DC, Staat MA, Selvarangan R, Shirley SH, Halasa N, Boom JA, Englund JA, Szilagyi PG, Harrison CJ, et al. Innate susceptibility to norovirus infections influenced by FUT2 genotype in a United States pediatric population. Clinical Infect Dis 2015; 60:1631-8; https://doi.org/http://dx.doi.org/10.1093/cid/civ165
- Kambhampati A, Payne DC, Costantini V, Lopman BA. Host genetic susceptibility to enteric viruses: A systematic review and metaanalysis. Clinical Infect Dis 2016; 62:11-8; https://doi.org/http://dx.doi.org/10.1093/cid/civ873
- Nordgren J, Sharma S, Bucardo F, Nasir W, Günaydın G, Ouermi D, Nitiema LW, Becker-Dreps S, Simpore J, Hammarström L, et al. Both Lewis and secretor status mediate susceptibility to rotavirus infections in a rotavirus genotype-dependent manner. Clinical Infect Dis 2014; 59:1567-73; https://doi.org/http://dx.doi.org/10.1093/cid/ciu633
- Imbert-Marcille BM, Barbé L, Dupé M, Le Moullac-Vaidye B, Besse B, Peltier C, Ruvoën-Clouet N, Le Pendu J. A FUT2 gene common polymorphism determines resistance to rotavirus A of the P[8]genotype. J Infect Dis 2014; 209:1227-30; PMID:24277741; https://doi.org/http://dx.doi.org/10.1093/infdis/jit655
- Bines JE, Danchin M, Jackson P, Handley A, Watts E, Lee KJ, West A, Cowley D, Chen MY, Barnes GL, et al. Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 2015; 15:1389-97; PMID:26318715; https://doi.org/http://dx.doi.org/10.1016/S1473-3099(15)00227-3
- Danchin M, Kirkwood CD, Lee KJ, Bishop RF, Watts E, Justice FA, Clifford V, Cowley D, Buttery JP, Bines JE, et al. Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine. Vaccine 2013; 31:2610-6; PMID:23597719; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2013.04.008
- Mijatovic-Rustempasic S, Tam KI, Kerin TK, Lewis JM, Gautam R, Quaye O, Gentsch JR, Bowen MD. Sensitive and specific quantitative detection of rotavirus a by one-step real-time reverse transcription PCR assay without antecedent dsRNA denaturation. J Clin Microbiol 2013; 9:3047-54; https://doi.org/http://dx.doi.org/10.1128/JCM.01192-13
- Gautam R, Esona MD, Mijatovic-Rustempasic S, Ian Tam K, Gentsch JR, Bowen MD. Real-time RT-PCR assays to differentiate wild-type group A rotavirus strains from Rotarix and RotaTeq vaccine strains in stool samples. Hum Vaccin Immunother 2014; 10:767-77; PMID:24342877; https://doi.org/http://dx.doi.org/10.4161/hv.27388
- Tate JE, Mijatovic-Rustempasic S, Tam KI, Lyde FC, Payne DC, Szilagyi P, Edwards K, Staat MA, Weinberg GA, Hall CB, et al. Comparison of 2 assays for diagnosing rotavirus and evaluating vaccine effectiveness in children with gastroenteritis. Emerg Infect Dis 2013; 19:1245-52; PMID:23876518; https://doi.org/http://dx.doi.org/10.3201/eid1908.130461
- Hsieh YC, Wu FT, Hsiung CA, Wu HS, Chang KY, Huang YC. Comparison of virus shedding after lived attenuated and pentavalent reassortant rotavirus vaccine. Vaccine 2014; 32:1199-204; PMID:24076325; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2013.08.041
- Mijatovic-Rustempasic S, Banyai K, Esona MD, Foytich K, Bowen MD, Gentsch JR. Genome sequence based molecular epidemiology of unusual US Rotavirus A G9 strains isolated from Omaha, USA between 1997 and 2000. Infect Genet Evol 2011; 11:522-7; PMID:21130184; https://doi.org/http://dx.doi.org/10.1016/j.meegid.2010.11.012
- Mijatovic-Rustempasic S, Frace MA, Bowen MD. Cost-effective paramagnetic bead technique for purification of cycle sequencing products. Sequencing 2012; 2012:4; https://doi.org/http://dx.doi.org/10.1155/2012/767959